Navigation Links
Rare Womens Lung Disease May Yield Insights Into Common Diseases

For many decades, medical research studies focused primarily on men and the results of countless studies were then applied to women. But we now know that the biological sex and gender differences between men and women are more than skin deep. Beginning in 1990, the Society for Womens Health Research, a Washington, D.C., based advocacy organization, conveyed to a national audience the need for including women in biomedical research studies. Today, research on women is robust.

Biomedical research can make an enormous difference in the lives of women. Take Dr. Elizabeth Petri Henske, M.D., the recipient of the 2007 Society for Womens Health Research Medtronic Prize for Scientific Contributions to Womens Health. The prize was established to recognize a women scientist or engineer for her contributions to womens health and encourage women to work on issues uniquely related to womens health.

Henske is an oncologist at the Fox Chase Cancer Center in Philadelphia, Pa. Her work focuses on the genetic and cellular mechanisms leading to two diseases not well-known to the public: tuberous sclerosis complex (TSC) and lymphangioleiomyomatosis (LAM).

LAM is a lung disease that almost exclusively affects young women. LAM has a stronger female predisposition than lupus or breast cancer, and may have the strongest biological sex predisposition of any human disease, except for diseases of the genital organs, and it is often fatal. Scientists estimate that there could be as many as 250,000 LAM patients worldwide.

LAM affects young women, and can strike suddenly during pregnancy, Henske said. LAM causes the lungs to fill with abnormal cells. As a result, cysts or holes can develop in the lung, causing it to collapse. The disease takes a major toll on the body, making even mundane tasks difficult. Women with LAM often need oxygen, are continuously short of breath, and are unable care for their children or walk up a flight of stairs , Henske said. Many women with LAM die prematurely.

As part of her work, Henske discovered that mutations in the tuberous sclerosis gene, which triggers TSC, a genetic disorder that causes tumors to form in many different organs, including the brain, eyes, heart, kidney, skin and lungs, plays a role in the cause of LAM. Her current work involves looking into the role female hormones play in the growth and metastasis of LAM cells.

Her tireless efforts have shed light on the connection between two diseases, provided understanding of the underlying mechanisms and hopefully will one day lead to a cure. By studying LAM we hope to develop treatments to eradicate LAM cells, and also learn more about how hormones cause abnormal cells to grow and metastasize, Henske said.

Henskes work may also benefit research on common diseases because the cellular pathways that are activated in tuberous sclerosis and LAM are also activated in many forms of cancer, and in diabetes and obesity. What is learned about LAM may help us understand more common diseases in which hormones play an important role, such as breast cancer. The impact of LAM research could spread to other diseases that are not hormonally dependent, she points out.

Despite the current advances being made by researchers like Henske, there is still an enormous amount that we do not yet understand about sex and gender differences in health and disease, ground that will hopefully be covered by researchers in the future.


'"/>




Related medicine news :

1. Cosmetic Genital Surgery may Be Fuelling Womens Insecurity About Their Bodies
2. Diabetic Womens Death Rate Shows No Decline
3. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
4. Vitamins-The answer to Heart Disease?
5. Link between Constipation and Parkinsons Disease
6. Levels Of Blood Proteins May Help Heart Disease Care
7. New Drug PP188 Helps Sickle Cell Disease
8. Gene Treatment for Heart Disease
9. Legume Consumption Can Cut Heart Disease Risk
10. Link Between Infection And Heart Disease
11. Celiac Disease in Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- In a startling report released today, National Safety Council ... comprehensive, proven plan to eliminate prescription opioid overdoses. Prescription ... are tackling the worst drug crisis in recorded U.S. history, assigned ... Kentucky , New Mexico , ... 28 failing states, three – Michigan , ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: